Nav: Home

Antipsychotic medication poses little risk to developing fetus

August 17, 2016

BOSTON, MA - Exposure to antipsychotic medications (APMs) during pregnancy is increasingly common. Widespread use of newer "atypical" drugs which are less likely to affect fertility than the older "typical" antipsychotics, combined with the deinstitutionalization of psychiatric patients, is attributed to doubling the use of antipsychotics during pregnancy in the past decade, yet, clinicians have little information regarding the safety of these drugs for the developing fetus and concerns have been raised about a potential association with congenital malformations.

In a new study at Brigham and Women's Hospital published in JAMA Psychiatry on August 17, 2016, researchers examined the risk of congenital malformations overall, and cardiac malformations in particular, in association with first trimester exposure to different APMs in a large population-based cohort study. Researchers found that the use of APMs in pregnancy does not meaningfully increase the risk of congenital malformations or cardiac malformations, with the possible exception of risperidone.

"Our findings help inform psychiatrists and their patients about the risk of using APMs during early pregnancy," stated Krista F.G. Huybrechts, MS, PhD, associate epidemiologist in the Division of Pharmacoepidemiology and Pharmacoeconomics at BWH. "In general, the use of any medication should be avoided during pregnancy. However, for women suffering from schizophrenia, bipolar disorder, or major depressive disorder, avoiding medication use is often impossible, given that there are very few alternative treatment options."

Huybrechts and her colleagues analyzed data from a nationwide sample of 1,341,715 pregnant women enrolled in Medicaid from three months before their last menstrual period through at least one month after delivery. Exposure to APMs was determined based on documentation which indicated that at least one prescription for APMs was filled during the first 90 days of pregnancy. Typical and atypical APMs were evaluated as two separate classes, as well as the most frequently used individual medications: aripiprazole, olanzapine, quetiapine, risperidone and ziprasidone.

Among the women studied, 9, 258 women (0.69 percent) filled a prescription for an atypical APM, and 733 women (0.05 percent) filed a prescription for a typical APM. Researchers found that 4.45 percent of births exposed to atypical APMs and 3.82 percent of births exposed to typical APMs were associated with congenital malformations. Among women who did not fill a prescription for an APM, 3.27 percent of births were diagnosed with congenital malformations. The findings for cardiac malformations were similar.

After controlling for other possible contributing mental and physical conditions and their associated behaviors, researchers found no significant increased risk for either congenital malformations or cardiac malformations among women who took either typical or atypical APMs in the first 90 days of pregnancy, with the possible exception of risperidone which continued to show a slightly increased risk.

"Further research is needed to assess whether the increased risk for risperidone reflects a true casual association or a chance finding," Huybrechts said.
-end-
This study was supported by grants R01MH100216 and K01MH099141 from the National Institute of Mental Health, grant K08HD075831 from the National Institute of Child health and Human Development and a Swiss National Science Foundation grant P3SMP3-158808/1.

Brigham and Women's Hospital (BWH) is a 793-bed nonprofit teaching affiliate of Harvard Medical School and a founding member of Partners HealthCare. BWH has more than 4.2 million annual patient visits and nearly 46,000 inpatient stays, is the largest birthing center in Massachusetts and employs nearly 16,000 people. The Brigham's medical preeminence dates back to 1832, and today that rich history in clinical care is coupled with its national leadership in patient care, quality improvement and patient safety initiatives, and its dedication to research, innovation, community engagement and educating and training the next generation of health care professionals. Through investigation and discovery conducted at its Brigham Research Institute (BRI), BWH is an international leader in basic, clinical and translational research on human diseases, more than 3,000 researchers, including physician-investigators and renowned biomedical scientists and faculty supported by nearly $666 million in funding. For the last 25 years, BWH ranked second in research funding from the National Institutes of Health (NIH) among independent hospitals. BWH is also home to major landmark epidemiologic population studies, including the Nurses' and Physicians' Health Studies and the Women's Health Initiative as well as the TIMI Study Group, one of the premier cardiovascular clinical trials groups. For more information, resources and to follow us on social media, please visit BWH's online newsroom.

Brigham and Women's Hospital

Related Pregnancy Articles:

Going to sleep on your back in late pregnancy
This study looked at whether going to sleep on your back in the third trimester of pregnancy was associated with average lower birth weights.
Opioid use disorder in pregnancy: 5 things to know
Opioid use is increasing in pregnancy as well as the general population.
Medical imaging rates during pregnancy
Researchers looked at rates of medical imaging (CT, MRI, conventional x-rays, angiography, fluoroscopy and nuclear medicine) during pregnancy in this observational study that included nearly 3.5 million pregnant women in the United States and Canada from 1996 to 2016.
New research on diet and supplements during pregnancy and beyond
The foods and nutrients a woman consumes while pregnant have important health implications for her and her baby.
Obesity in early pregnancy linked to pregnancy complications
In a prospective study published in Obesity of 18,481 pregnant women in China who had never given birth before, obesity in early pregnancy was linked to higher risks of spontaneous abortion, preterm birth, and large birth weight in newborns.
Possible link between autism and antidepressants use during pregnancy
An international team led by Duke-NUS Medical School has found a potential link between autistic-like behaviour in adult mice and exposure to a common antidepressant in the womb.
Immigrant women more likely to be overweight during pregnancy
A new study in the Journal of Public Health finds that women in Norway from immigrant backgrounds are more likely to be overweight during pregnancy.
Stillbirths more likely if diabetes in pregnancy not diagnosed
Women who develop diabetes in pregnancy but are not diagnosed are much more likely to experience stillbirth than women without the condition, according to new research.
Do economic conditions affect pregnancy outcomes?
Economic downturn during early pregnancy was linked with modest increases in preterm birth in a Paediatric and Perinatal Epidemiology analysis.
Birthweight and early pregnancy body mass index may risk pregnancy complications
Women who were born with a low birthweight are at increased risk of pregnancy complications, according to a new Obesity study.
More Pregnancy News and Pregnancy Current Events

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Rethinking Anger
Anger is universal and complex: it can be quiet, festering, justified, vengeful, and destructive. This hour, TED speakers explore the many sides of anger, why we need it, and who's allowed to feel it. Guests include psychologists Ryan Martin and Russell Kolts, writer Soraya Chemaly, former talk radio host Lisa Fritsch, and business professor Dan Moshavi.
Now Playing: Science for the People

#538 Nobels and Astrophysics
This week we start with this year's physics Nobel Prize awarded to Jim Peebles, Michel Mayor, and Didier Queloz and finish with a discussion of the Nobel Prizes as a way to award and highlight important science. Are they still relevant? When science breakthroughs are built on the backs of hundreds -- and sometimes thousands -- of people's hard work, how do you pick just three to highlight? Join host Rachelle Saunders and astrophysicist, author, and science communicator Ethan Siegel for their chat about astrophysics and Nobel Prizes.